GSK and UK reach swine flu Pandemrix deal
This article was originally published in Scrip
Executive Summary
The UK’s Department of Health has capped UK orders of GlaxoSmithKline's A (H1N1) vaccine Pandemrix at 34.8 million doses, it said yesterday as swine flu cases have reached their lowest levels yet.